Publications by authors named "Lisa Dunkle"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

230,141

Total Likes

4,707

Extended Reach

1,125,949

Social Features

254
A
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine.
Youyi Fong, Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry, Lisa M Dunkle

Clin Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19).
Germán Áñez, Alice McGarry, Wayne Woo, Karen L Kotloff, Cynthia L Gay, Lisa M Dunkle

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform-specific priming and immune imprinting.
Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, Anand Parekh, Drew Gorinson, Lisa M Dunkle

J Infect· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine doses.
Jeffrey M Adelglass, Paul Bradley, Miranda R Cai, Gordon Chau, Raj Kalkeri, Lisa M Dunkle

J Allergy Clin Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
Holly Janes, Leigh H Fisher, Jia Jin Kee, Lalitha Parameswaran, Paul A Goepfert, Lisa Dunkle

J Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines.
Anthony M Marchese, Louis Fries, Hadi Beyhaghi, Muruga Vadivale, Mingzhu Zhu, Lisa M Dunkle

J Infect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials.
Amy C Sherman, Jessica Tuan, Valeria D Cantos, Oladunni Adeyiga, Scott Mahoney, Lisa M Dunkle

Clin Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
Dean Follmann, Allyson Mateja, Michael P Fay, Craig A Magaret, Yunda Huang, Lisa M Dunkle

Clin Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Leigh H Fisher, Jia Jin Kee, Albert Liu, Claudia M Espinosa, April K Randhawa, Lisa M Dunkle

JAMA Netw Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines.
Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, Joyce S Plested, Anand Parekh, Lisa M Dunkle

J Infect· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines.
Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, Joyce S Plested, Anand Parekh, Lisa M Dunkle

medRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of COVID-19 after natural infection or vaccination.
Anne-Marie Rick, Matthew B Laurens, Ying Huang, Chenchen Yu, Thomas C S Martin, Lisa M Dunkle

EBioMedicine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults.
Fritz Raiser, Matthew Davis, Jeffrey Adelglass, Miranda R Cai, Gordon Chau, Lisa M Dunkle

Vaccine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials.
Christine B Turley, LaKesha Tables, Trevon Fuller, Lisa J Sanders, Hyman Scott, Lisa M Dunkle

Vaccine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Deborah A Theodore, Angela R Branche, Lily Zhang, Daniel S Graciaa, Madhu Choudhary, Lisa M Dunkle

JAMA Netw Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine.
Eddie Underwood, Lisa M Dunkle, Shabir A Madhi, Cynthia L Gay, Paul T Heath

Expert Rev Vaccines· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial.
Anthony M Marchese, Xiang Zhou, John Kinol, Eddie Underwood, Wayne Woo, Lisa M Dunkle

Vaccine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of NVX-CoV2373 in PREVENT-19: A Phase 3, Randomized, Placebo-Controlled Trial in Adults in the United States and Mexico.
Germán Áñez, Karen L Kotloff, Cynthia L Gay, Joy Nelson, Haoua Dunbar, Lisa M Dunkle

medRxiv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial.
Germán Áñez, Lisa M Dunkle, Cynthia L Gay, Karen L Kotloff, Jeffrey M Adelglass

JAMA Netw Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.
Youyi Fong, Yunda Huang, David Benkeser, Lindsay N Carpp, Germán Áñez, Lisa M Dunkle

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.
Youyi Fong, Yunda Huang, David Benkeser, Lindsay N Carpp, Germán Áñez, Lisa M Dunkle

Nat Commun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Immunogenicity and Efficacy of NVX-CoV2373 in Adolescents in PREVENT-19: A Randomized, Phase 3 Trial.
Germán Áñez, Lisa M Dunkle, Cynthia L Gay, Karen L Kotloff, Jeffrey M Adelglass

medRxiv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study.
John Hansen, Kristin Goddard, Julius Timbol, Lea Zhang, Ned Lewis, Lisa Dunkle

Open Forum Infect Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial.
Lisa M Dunkle, Ruvim Izikson, Peter A Patriarca, Karen L Goldenthal, Manon Cox

Pediatrics· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis